MX2022012033A - Agente terapeutico para infeccion por coronavirus. - Google Patents
Agente terapeutico para infeccion por coronavirus.Info
- Publication number
- MX2022012033A MX2022012033A MX2022012033A MX2022012033A MX2022012033A MX 2022012033 A MX2022012033 A MX 2022012033A MX 2022012033 A MX2022012033 A MX 2022012033A MX 2022012033 A MX2022012033 A MX 2022012033A MX 2022012033 A MX2022012033 A MX 2022012033A
- Authority
- MX
- Mexico
- Prior art keywords
- coronavirus infection
- treatment drug
- infection treatment
- coronavirus
- pyrradine
- Prior art date
Links
- 208000001528 Coronaviridae Infections Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000026425 severe pneumonia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La infección por coronavirus se puede tratar mediante la administración de una composición farmacéutica que comprende 6-fluoro-3-hidroxi-2-pirazincarboxamida o una sal de la misma como ingrediente activo a un paciente con infección por coronavirus con neumonía no grave.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020061411 | 2020-03-30 | ||
| JP2020156253 | 2020-09-17 | ||
| PCT/JP2021/012858 WO2021200651A1 (ja) | 2020-03-30 | 2021-03-26 | コロナウイルス感染症治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022012033A true MX2022012033A (es) | 2022-10-27 |
Family
ID=77927283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022012033A MX2022012033A (es) | 2020-03-30 | 2021-03-26 | Agente terapeutico para infeccion por coronavirus. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230127703A1 (es) |
| EP (1) | EP4129291A4 (es) |
| JP (1) | JPWO2021200651A1 (es) |
| CN (1) | CN115884774A (es) |
| AU (1) | AU2021245634A1 (es) |
| BR (1) | BR112022019486A2 (es) |
| CA (1) | CA3173148A1 (es) |
| MX (1) | MX2022012033A (es) |
| TW (1) | TW202203923A (es) |
| WO (1) | WO2021200651A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000010569A1 (fr) | 1998-08-20 | 2000-03-02 | Toyama Chemical Co., Ltd. | Derives heterocycliques azotes de carboxamide ou certains de leurs sels et antiviraux les contenant les deux |
| EP2407166B1 (en) | 2009-03-13 | 2013-08-21 | Toyama Chemical Co., Ltd. | Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| EP3210993B1 (en) * | 2012-03-13 | 2018-12-12 | Gilead Sciences, Inc. | 2'- substituted carba-nucleoside analogs for antiviral treatment |
| CN111265528A (zh) * | 2020-01-21 | 2020-06-12 | 中国人民解放军军事科学院军事医学研究院 | 法匹拉韦在治疗冠状病毒感染方面的应用 |
-
2021
- 2021-03-26 BR BR112022019486A patent/BR112022019486A2/pt unknown
- 2021-03-26 CN CN202180031625.2A patent/CN115884774A/zh active Pending
- 2021-03-26 EP EP21779525.1A patent/EP4129291A4/en active Pending
- 2021-03-26 CA CA3173148A patent/CA3173148A1/en active Pending
- 2021-03-26 WO PCT/JP2021/012858 patent/WO2021200651A1/ja unknown
- 2021-03-26 US US17/907,722 patent/US20230127703A1/en active Pending
- 2021-03-26 AU AU2021245634A patent/AU2021245634A1/en active Pending
- 2021-03-26 MX MX2022012033A patent/MX2022012033A/es unknown
- 2021-03-26 JP JP2022512114A patent/JPWO2021200651A1/ja active Pending
- 2021-03-30 TW TW110111489A patent/TW202203923A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2021200651A1 (es) | 2021-10-07 |
| WO2021200651A1 (ja) | 2021-10-07 |
| EP4129291A1 (en) | 2023-02-08 |
| EP4129291A4 (en) | 2024-04-10 |
| BR112022019486A2 (pt) | 2022-11-16 |
| CA3173148A1 (en) | 2021-10-07 |
| CN115884774A (zh) | 2023-03-31 |
| US20230127703A1 (en) | 2023-04-27 |
| AU2021245634A1 (en) | 2022-10-20 |
| TW202203923A (zh) | 2022-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202109010B (en) | Compounds and methods for the treatment of covid-19 | |
| MX2012007410A (es) | Compuestos antivirales novedosos. | |
| MX2022003072A (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
| EA201690069A1 (ru) | Применение высоких доз придопидина для лечения болезни хантингтона | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| PH12019501363A1 (en) | Insulin containing pharmaceutical compositions | |
| MX2011011058A (es) | Antagonistas del receptor ep4 para el tratamiento de cancer. | |
| JOP20200031A1 (ar) | طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة | |
| MX2021009219A (es) | Triamtereno o nolatrexed para su uso en el tratamiento de la fenilcetonuria. | |
| PH12015502128A1 (en) | Novel dosing regimens of celgosivir for the treatment of dengue | |
| RU2015112121A (ru) | Ми-рнк и их применение в способах и композициях для лечения и/или профилактики глазных состояний | |
| PH12018501769A1 (en) | Medicament for treatment of diabetic foot infections | |
| EA202192483A1 (ru) | Лекарственное средство и способ лечения или профилактики осложнений диабета с использованием этого лекарственного средства | |
| MX2022012033A (es) | Agente terapeutico para infeccion por coronavirus. | |
| EA202190317A1 (ru) | Лекарственный препарат для наружного применения | |
| EA201590350A1 (ru) | Комбинации с пептидом с циклизованной основной цепью | |
| MX2022012001A (es) | Tratamiento preventivo de la migra?a. | |
| MX2022011565A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2008011321A (es) | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual. | |
| MX2014015096A (es) | Alimento para crustaceos. | |
| RU2014141112A (ru) | Метаболит илоперидона для применения при лечении психических расстройств | |
| RU2012114097A (ru) | Терапевтический агент против хронической боли | |
| EA201990553A1 (ru) | Применение придопидина для лечения ухудшения функциональной способности | |
| RU2011111673A (ru) | Способ и средство для лечения экссудативного среднего отита | |
| RU2013142835A (ru) | Способ лечения ишемического инсульта |